Cargando…
Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome
INTRODUCTION: Twenty-four-hour urinary free cortisol (24h-UFC) is the most used test for follow-up decision-making in patients with Cushing syndrome (CS) under medical treatment. However, 24h-UFC determinations by immunoassays (IA) are commonly overestimated because of steroid metabolites’ cross-rea...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905543/ https://www.ncbi.nlm.nih.gov/pubmed/35282465 http://dx.doi.org/10.3389/fendo.2022.833644 |
_version_ | 1784665210548649984 |
---|---|
author | Vega-Beyhart, Arturo Laguna-Moreno, Javier Díaz-Catalán, Daniela Boswell, Laura Mora, Mireia Halperin, Irene Casals, Gregori Hanzu, Felicia A. |
author_facet | Vega-Beyhart, Arturo Laguna-Moreno, Javier Díaz-Catalán, Daniela Boswell, Laura Mora, Mireia Halperin, Irene Casals, Gregori Hanzu, Felicia A. |
author_sort | Vega-Beyhart, Arturo |
collection | PubMed |
description | INTRODUCTION: Twenty-four-hour urinary free cortisol (24h-UFC) is the most used test for follow-up decision-making in patients with Cushing syndrome (CS) under medical treatment. However, 24h-UFC determinations by immunoassays (IA) are commonly overestimated because of steroid metabolites’ cross-reaction. It is still uncertain how ketoconazole (KTZ)- and metyrapone (MTP)-induced changes on the urinary steroid metabolites can alter the 24h-UFC*IA determinations’ reliability. METHODS: 24h-UFC was analyzed by IA and gas chromatography-mass spectrometry (GC-MS) in 193 samples (81 before treatment, 73 during KTZ, and 39 during MTP) from 34 CS patients. In addition, urinary steroidome was analyzed by GC-MS on each patient before and during treatment. RESULTS: Before treatment, 24h-UFC*IA determinations were overestimated by a factor of 1.75 (95% CI 1.60–1.94) compared to those by GC-MS. However, during KTZ treatment, 24h-UFC*IA results were similar (0.98:1) to those by GC-MS (95% CI, 0.83–1.20). In patients taking MTP, IA bias only decreased 0.55, resulting in persistence of an overestimation factor of 1.33:1 (95% CI, 1.09–1.76). High method agreement between GC-MS and IA before treatment (R(2) = 0.954) declined in patients under KTZ (R(2) = 0.632) but not in MTP (R(2) = 0.917). Upper limit normal (ULN) reductions in patients taking KTZ were 27% larger when using 24h-UFC*IA compared to 24h-UFC*GC-MS, which resulted in higher false efficacy and misleading biochemical classification of 15% of patients. Urinary excretion changes of 22 urinary steroid metabolites explained 86% of the 24h-UFC*IA interference. Larger urinary excretion reductions of 6β-hydroxy-cortisol, 20α-dihydrocortisol, and 18-hydroxy-cortisol in patients with KTZ elucidated the higher 24h-UFC*IA bias decrement compared to MTP-treated patients. CONCLUSION: KTZ and MTP alter the urinary excretion of IA cross-reactive steroid metabolites, thus decreasing the cross-reactive interference of 24h-UFC*IA determinations present before treatment. Consequently, this interference reduction in 24h-UFC*IA leads to loss of method agreement with GC-MS and high risk of overestimating the biochemical impact of KTZ and MTP in controlling CS because of poor reliability of reference ranges and ULN. |
format | Online Article Text |
id | pubmed-8905543 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89055432022-03-10 Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome Vega-Beyhart, Arturo Laguna-Moreno, Javier Díaz-Catalán, Daniela Boswell, Laura Mora, Mireia Halperin, Irene Casals, Gregori Hanzu, Felicia A. Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Twenty-four-hour urinary free cortisol (24h-UFC) is the most used test for follow-up decision-making in patients with Cushing syndrome (CS) under medical treatment. However, 24h-UFC determinations by immunoassays (IA) are commonly overestimated because of steroid metabolites’ cross-reaction. It is still uncertain how ketoconazole (KTZ)- and metyrapone (MTP)-induced changes on the urinary steroid metabolites can alter the 24h-UFC*IA determinations’ reliability. METHODS: 24h-UFC was analyzed by IA and gas chromatography-mass spectrometry (GC-MS) in 193 samples (81 before treatment, 73 during KTZ, and 39 during MTP) from 34 CS patients. In addition, urinary steroidome was analyzed by GC-MS on each patient before and during treatment. RESULTS: Before treatment, 24h-UFC*IA determinations were overestimated by a factor of 1.75 (95% CI 1.60–1.94) compared to those by GC-MS. However, during KTZ treatment, 24h-UFC*IA results were similar (0.98:1) to those by GC-MS (95% CI, 0.83–1.20). In patients taking MTP, IA bias only decreased 0.55, resulting in persistence of an overestimation factor of 1.33:1 (95% CI, 1.09–1.76). High method agreement between GC-MS and IA before treatment (R(2) = 0.954) declined in patients under KTZ (R(2) = 0.632) but not in MTP (R(2) = 0.917). Upper limit normal (ULN) reductions in patients taking KTZ were 27% larger when using 24h-UFC*IA compared to 24h-UFC*GC-MS, which resulted in higher false efficacy and misleading biochemical classification of 15% of patients. Urinary excretion changes of 22 urinary steroid metabolites explained 86% of the 24h-UFC*IA interference. Larger urinary excretion reductions of 6β-hydroxy-cortisol, 20α-dihydrocortisol, and 18-hydroxy-cortisol in patients with KTZ elucidated the higher 24h-UFC*IA bias decrement compared to MTP-treated patients. CONCLUSION: KTZ and MTP alter the urinary excretion of IA cross-reactive steroid metabolites, thus decreasing the cross-reactive interference of 24h-UFC*IA determinations present before treatment. Consequently, this interference reduction in 24h-UFC*IA leads to loss of method agreement with GC-MS and high risk of overestimating the biochemical impact of KTZ and MTP in controlling CS because of poor reliability of reference ranges and ULN. Frontiers Media S.A. 2022-02-23 /pmc/articles/PMC8905543/ /pubmed/35282465 http://dx.doi.org/10.3389/fendo.2022.833644 Text en Copyright © 2022 Vega-Beyhart, Laguna-Moreno, Díaz-Catalán, Boswell, Mora, Halperin, Casals and Hanzu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Vega-Beyhart, Arturo Laguna-Moreno, Javier Díaz-Catalán, Daniela Boswell, Laura Mora, Mireia Halperin, Irene Casals, Gregori Hanzu, Felicia A. Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome |
title | Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome |
title_full | Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome |
title_fullStr | Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome |
title_full_unstemmed | Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome |
title_short | Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome |
title_sort | ketoconazole- and metyrapone-induced reductions on urinary steroid metabolites alter the urinary free cortisol immunoassay reliability in cushing syndrome |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905543/ https://www.ncbi.nlm.nih.gov/pubmed/35282465 http://dx.doi.org/10.3389/fendo.2022.833644 |
work_keys_str_mv | AT vegabeyhartarturo ketoconazoleandmetyraponeinducedreductionsonurinarysteroidmetabolitesaltertheurinaryfreecortisolimmunoassayreliabilityincushingsyndrome AT lagunamorenojavier ketoconazoleandmetyraponeinducedreductionsonurinarysteroidmetabolitesaltertheurinaryfreecortisolimmunoassayreliabilityincushingsyndrome AT diazcatalandaniela ketoconazoleandmetyraponeinducedreductionsonurinarysteroidmetabolitesaltertheurinaryfreecortisolimmunoassayreliabilityincushingsyndrome AT boswelllaura ketoconazoleandmetyraponeinducedreductionsonurinarysteroidmetabolitesaltertheurinaryfreecortisolimmunoassayreliabilityincushingsyndrome AT moramireia ketoconazoleandmetyraponeinducedreductionsonurinarysteroidmetabolitesaltertheurinaryfreecortisolimmunoassayreliabilityincushingsyndrome AT halperinirene ketoconazoleandmetyraponeinducedreductionsonurinarysteroidmetabolitesaltertheurinaryfreecortisolimmunoassayreliabilityincushingsyndrome AT casalsgregori ketoconazoleandmetyraponeinducedreductionsonurinarysteroidmetabolitesaltertheurinaryfreecortisolimmunoassayreliabilityincushingsyndrome AT hanzufeliciaa ketoconazoleandmetyraponeinducedreductionsonurinarysteroidmetabolitesaltertheurinaryfreecortisolimmunoassayreliabilityincushingsyndrome |